September 29, 2026—iVascular announced new phase 2 data from the OPAL study of Amber, the company’s liquid embolic. The ...

The Society of Interventional Radiology (SIR) announced the publication of a study demonstrating that embolization greatly re ...

VS3 Medical, Inc., a developer of neurovascular implants, announced that the company’s VS3 system has been granted FDA ...

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced the start of patient enrollment in the ...

Route 92 Medical, Inc. announced FDA 510(k) clearance for the FreeClimb 46 catheter with Tenzing 4. The two components are en ...

Anaconda Biomed, a developer of a portfolio of thrombectomy catheters based on its core funnel catheter technology platform, ...

Mölnlycke Health Care US, LLC. announced the launch of the company’s range of Biogel radiation protection gloves, ...

Pulnovo Medical, a China-based developer of medical devices for pulmonary hypertension (PH) and heart failure (HF), announced ...

Italy-based Dialybrid S.r.l. announced commencement of the first-in-human (FIH) trial of the company’s arteriovenous (A ...

Piraeus Medical, Inc. announced the United States launch and first clinical cases of the company’s 6-F 70 NeuGlide cath ...

GE HealthCare announced it has received CE Mark approval for Photonova Spectra, a photon-counting CT (PCCT) system with the c ...

Dr. Amit Dwivedi offers his perspective on patient selection criteria for the DETOUR System, including patient and lesion ...